NCT01581242View on ClinicalTrials.gov

A Clinical Trial to Investigate the Pharmacokinetic Drug-drug Interaction of Clevudine and Adefovir Dipivoxil After Oral Administration in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

June 30, 2012

Conditions
Healthy
Interventions
DRUG

Clevudine, Adefovir dipivoxil , Clevudine+Adefovir dipivoxil

Clevudine 20mg qd Days 1; Adefovir dipivoxil 10 mg qd Days 8;Clevudine 20mg +Adefovir dipivoxil 10mg qd Days 15

DRUG

Clevudine; Adefovir dipivoxil ,Clevudine +Adefovir dipivoxil

Clevudine 20mg +Adefovir dipivoxil 10mg qd Days 1; Clevudine 20mg qd Days 8; Adefovir dipivoxil 10 mg qd Days 15;

DRUG

Clevudine,Adefovir dipivoxil ,Clevudine +Adefovir dipivoxil

Adefovir dipivoxil 10 mg qd Days 1;Clevudine 20mg +Adefovir dipivoxil 10mg qd Days 8; Clevudine 20mg qd Days 15

Trial Locations (1)

Unknown

Clinical Trial Center, Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Bukwang Pharmaceutical

INDUSTRY

NCT01581242 - A Clinical Trial to Investigate the Pharmacokinetic Drug-drug Interaction of Clevudine and Adefovir Dipivoxil After Oral Administration in Healthy Male Subjects | Biotech Hunter | Biotech Hunter